Cargando…
Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015
Background: Direct comparisons between countries in core HIV care parameters are often hampered by differences in data collection. Aim: Within the EuroSIDA study, we compared levels of antiretroviral treatment (ART) coverage and virological suppression (HIV RNA < 500 copies/mL) across Europe and...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152212/ https://www.ncbi.nlm.nih.gov/pubmed/29845931 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.21.1700382 |
_version_ | 1783357319414808576 |
---|---|
author | Laut, Kamilla Shepherd, Leah Radoi, Roxana Karpov, Igor Parczewski, Milosz Mussini, Cristina Maltez, Fernando Losso, Marcelo Chkhartishvili, Nikoloz Elinav, Hila Kovari, Helen Blaxhult, Anders Zangerle, Robert Trofimova, Tatiana Inglot, Malgorzata Zilmer, Kai Kuzovatova, Elena Staub, Thérèse Raben, Dorthe Lundgren, Jens Mocroft, Amanda Kirk, Ole |
author_facet | Laut, Kamilla Shepherd, Leah Radoi, Roxana Karpov, Igor Parczewski, Milosz Mussini, Cristina Maltez, Fernando Losso, Marcelo Chkhartishvili, Nikoloz Elinav, Hila Kovari, Helen Blaxhult, Anders Zangerle, Robert Trofimova, Tatiana Inglot, Malgorzata Zilmer, Kai Kuzovatova, Elena Staub, Thérèse Raben, Dorthe Lundgren, Jens Mocroft, Amanda Kirk, Ole |
author_sort | Laut, Kamilla |
collection | PubMed |
description | Background: Direct comparisons between countries in core HIV care parameters are often hampered by differences in data collection. Aim: Within the EuroSIDA study, we compared levels of antiretroviral treatment (ART) coverage and virological suppression (HIV RNA < 500 copies/mL) across Europe and explored temporal trends. Methods: In three cross-sectional analyses in 2004–05, 2009–10 and 2014–15, we assessed country-specific percentages of ART coverage and virological suppression among those on ART. Temporal changes were analysed using logistic regression. Results: Overall, the percentage of people on ART increased from 2004–05 (67.8%) to 2014–15 (78.2%), as did the percentage among those on ART who were virologically suppressed (75.2% in 2004–05, 87.7% in 2014–15). However, the rate of improvement over time varied significantly between regions (p < 0.01). In 2014–15, six of 34 countries had both ART coverage and virological suppression of above 90% among those on ART. The pattern varied substantially across clinics within countries, with ART coverage ranging from 61.9% to 97.0% and virological suppression from 32.2% to 100%. Compared with Western Europe (as defined in this study), patients in other regions were less likely to be virologically suppressed in 2014–15, with the lowest odds of suppression (adjusted odds ratio = 0.16; 95% confidence interval (CI): 0.13–0.21) in Eastern Europe. Conclusions: Despite overall improvements over a decade, we found persistent disparities in country-specific estimates of ART coverage and virological suppression. Underlying reasons for this variation warrant further analysis to identify a best practice and benchmark HIV care across EuroSIDA. |
format | Online Article Text |
id | pubmed-6152212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | European Centre for Disease Prevention and Control (ECDC) |
record_format | MEDLINE/PubMed |
spelling | pubmed-61522122018-10-19 Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015 Laut, Kamilla Shepherd, Leah Radoi, Roxana Karpov, Igor Parczewski, Milosz Mussini, Cristina Maltez, Fernando Losso, Marcelo Chkhartishvili, Nikoloz Elinav, Hila Kovari, Helen Blaxhult, Anders Zangerle, Robert Trofimova, Tatiana Inglot, Malgorzata Zilmer, Kai Kuzovatova, Elena Staub, Thérèse Raben, Dorthe Lundgren, Jens Mocroft, Amanda Kirk, Ole Euro Surveill Research Article Background: Direct comparisons between countries in core HIV care parameters are often hampered by differences in data collection. Aim: Within the EuroSIDA study, we compared levels of antiretroviral treatment (ART) coverage and virological suppression (HIV RNA < 500 copies/mL) across Europe and explored temporal trends. Methods: In three cross-sectional analyses in 2004–05, 2009–10 and 2014–15, we assessed country-specific percentages of ART coverage and virological suppression among those on ART. Temporal changes were analysed using logistic regression. Results: Overall, the percentage of people on ART increased from 2004–05 (67.8%) to 2014–15 (78.2%), as did the percentage among those on ART who were virologically suppressed (75.2% in 2004–05, 87.7% in 2014–15). However, the rate of improvement over time varied significantly between regions (p < 0.01). In 2014–15, six of 34 countries had both ART coverage and virological suppression of above 90% among those on ART. The pattern varied substantially across clinics within countries, with ART coverage ranging from 61.9% to 97.0% and virological suppression from 32.2% to 100%. Compared with Western Europe (as defined in this study), patients in other regions were less likely to be virologically suppressed in 2014–15, with the lowest odds of suppression (adjusted odds ratio = 0.16; 95% confidence interval (CI): 0.13–0.21) in Eastern Europe. Conclusions: Despite overall improvements over a decade, we found persistent disparities in country-specific estimates of ART coverage and virological suppression. Underlying reasons for this variation warrant further analysis to identify a best practice and benchmark HIV care across EuroSIDA. European Centre for Disease Prevention and Control (ECDC) 2018-05-24 /pmc/articles/PMC6152212/ /pubmed/29845931 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.21.1700382 Text en This article is copyright of The Authors, 2018. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
spellingShingle | Research Article Laut, Kamilla Shepherd, Leah Radoi, Roxana Karpov, Igor Parczewski, Milosz Mussini, Cristina Maltez, Fernando Losso, Marcelo Chkhartishvili, Nikoloz Elinav, Hila Kovari, Helen Blaxhult, Anders Zangerle, Robert Trofimova, Tatiana Inglot, Malgorzata Zilmer, Kai Kuzovatova, Elena Staub, Thérèse Raben, Dorthe Lundgren, Jens Mocroft, Amanda Kirk, Ole Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015 |
title | Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015 |
title_full | Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015 |
title_fullStr | Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015 |
title_full_unstemmed | Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015 |
title_short | Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015 |
title_sort | persistent disparities in antiretroviral treatment (art) coverage and virological suppression across europe, 2004 to 2015 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152212/ https://www.ncbi.nlm.nih.gov/pubmed/29845931 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.21.1700382 |
work_keys_str_mv | AT lautkamilla persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT shepherdleah persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT radoiroxana persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT karpovigor persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT parczewskimilosz persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT mussinicristina persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT maltezfernando persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT lossomarcelo persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT chkhartishvilinikoloz persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT elinavhila persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT kovarihelen persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT blaxhultanders persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT zangerlerobert persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT trofimovatatiana persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT inglotmalgorzata persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT zilmerkai persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT kuzovatovaelena persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT staubtherese persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT rabendorthe persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT lundgrenjens persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT mocroftamanda persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT kirkole persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 AT persistentdisparitiesinantiretroviraltreatmentartcoverageandvirologicalsuppressionacrosseurope2004to2015 |